Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails

dc.authorid0000-0001-5352-8683
dc.authorid0000-0002-1777-9001
dc.authorid0000-0002-9158-7243
dc.contributor.authorAsh, Zoe R.
dc.contributor.authorTinazzi, Ilaria
dc.contributor.authorCastillo-Gallego, Concepcion
dc.contributor.authorKwok, Chung
dc.contributor.authorWilson, Caroline
dc.contributor.authorGoodfield, Mark
dc.contributor.authorGisondi, Paolo
dc.date.accessioned2025-05-10T19:40:35Z
dc.date.issued2012
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective Enthesopathy is a major feature of psoriatic arthritis (PsA), which is supported by imaging studies. Given that nail disease often predates PsA and that the nail is directly anchored to entheses, the authors asked whether nail involvement in psoriasis equates with a systemic enthesopathy. Methods Forty-six patients with psoriasis (31 with nail disease) and 21 matched healthy controls (HC) were recruited. 804 entheses of upper and lower limbs were scanned by an ultrasonographer blinded to clinical details. Results Psoriasis patients had higher enthesitis scores than HC (median (range) 21 (0-65) vs 11 (3-39), p=0.005). Enthesopathy scores were higher in patients with nail disease (23 (0-65)) than in patients without nail disease (15 (5-26), p=0.02) and HC (11 (3-39), p=0.003). Inflammation scores of patients with nail disease (13 (0-34)) were higher than patients without nail disease (8 (2-15), p=0.02) and HC (5 (0-19), p<0.001). Modified nail psoriasis severity index scores were correlated to both inflammation (r(2)=0.45, p=0.005) and chronicity scores (r(2)=0.35, p=0.04). No link between the psoriasis area and severity index and enthesitis was evident. Conclusion The link between nail disease and contemporaneous subclinical enthesopathy offers a novel anatomical basis for the predictive value of nail psoriasis for PsA evolution.
dc.description.sponsorshipMerck Sharp Dohme Ltd; National Institute for Health Research; Society for Education and Research in Rheumatology in Turkey; EULAR; Spanish Foundation of Rheumatology
dc.description.sponsorshipThis study was supported by an unrestricted educational grant from Merck Sharp & Dohme Ltd with part funding also from the National Institute for Health Research. SZA had a grant from the Society for Education and Research in Rheumatology in Turkey. CCG was funded by EULAR and the Spanish Foundation of Rheumatology grants.
dc.identifier.doi10.1136/annrheumdis-2011-200478
dc.identifier.endpage556
dc.identifier.issn0003-4967
dc.identifier.issue4
dc.identifier.pmid22156725
dc.identifier.scopusqualityQ1
dc.identifier.startpage553
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2011-200478
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10036
dc.identifier.volume71
dc.identifier.wosWOS:000301066500015
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherB M J Publishing Group
dc.relation.ispartofAnnals of The Rheumatic Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectLower-Limb
dc.subjectArthritis
dc.subjectInvolvement
dc.subjectArthropathy
dc.subjectPrevalence
dc.subjectEnthesis
dc.subjectRisk
dc.titlePsoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
10036.pdf
Boyut:
177.68 KB
Biçim:
Adobe Portable Document Format